Your browser doesn't support javascript.
loading
T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors.
Tsimberidou, Apostolia-Maria; Van Morris, Karlyle; Vo, Henry Hiep; Eck, Stephen; Lin, Yu-Feng; Rivas, Jorge Mauricio; Andersson, Borje S.
Afiliação
  • Tsimberidou AM; Department of Investigational Cancer Therapeutics, Unit 455, Phase I Clinical Trials Program, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. atsimber@mdanderson.org.
  • Van Morris K; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
  • Vo HH; Department of Investigational Cancer Therapeutics, Unit 455, Phase I Clinical Trials Program, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
  • Eck S; MacroGenics, Inc., 9704 Medical Center Drive, Rockville, MD, 20850, USA.
  • Lin YF; Immatics US, Inc., 2201 Holcombe Blvd., Suite 205, Houston, TX, 77030, USA.
  • Rivas JM; Immatics US, Inc., 2201 Holcombe Blvd., Suite 205, Houston, TX, 77030, USA.
  • Andersson BS; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
J Hematol Oncol ; 14(1): 102, 2021 06 30.
Article em En | MEDLINE | ID: mdl-34193217

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article